At presentation, patients in the NAFLD group had significantly higher HGI, age, BMI, WC, TG, TC, AST, ALT, GGT, SBP, DBP, and lower HDL-C levels than patients in the non-NAFLD group. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.